Aclaris Therapeutics ACRS Total Cost of Revenue
Total Cost of Revenue at other companies
Other financials
Where this comes from
Reported directly by Aclaris Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:CostOfRevenue.
The official record: Aclaris Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aclaris Therapeutics's total cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aclaris Therapeutics's total cost of revenue?
- Aclaris Therapeutics (ACRS) reported total cost of revenue of $395K in Q1 2026.
- How has Aclaris Therapeutics's total cost of revenue changed year-over-year?
- Aclaris Therapeutics's total cost of revenue decreased by 21.9% year-over-year, from $506K to $395K.
- What is the long-term trend for Aclaris Therapeutics's total cost of revenue?
- Over 4 years (2021 to 2025), Aclaris Therapeutics's total cost of revenue has grown at a -18.4% compound annual growth rate (CAGR), from $4.71M to $2.09M.
- What does total cost of revenue mean?
- The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.